Notice2023-04701
Board of Scientific Counselors, National Institute for Occupational Safety and Health
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 8, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with regulatory provisions, the Centers for Disease Control and Prevention announces the following meeting of the Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH). This is a virtual meeting. It is open to the public, limited only by the number of web conference lines (500 web conference lines are available). Time will be available for public comment.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 45 (Wednesday, March 8, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 45 (Wednesday, March 8, 2023)]
[Notices]
[Pages 14371-14372]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-04701]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2023-0015; NIOSH 278]
Board of Scientific Counselors, National Institute for
Occupational Safety and Health
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention announces the following meeting of the
Board of Scientific Counselors, National Institute for Occupational
Safety and Health (BSC, NIOSH). This is a virtual meeting. It is open
to the public, limited only by the number of web conference lines (500
web conference lines are available). Time will be available for public
comment.
DATES: The meeting will be held on April 21, 2023, from 10 a.m. to 3
p.m., EDT.
Written comments must be received on or before April 14, 2023.
ADDRESSES: If you wish to attend the meeting, please register at the
NIOSH website at <a href="https://www.cdc.gov/niosh/bsc/">https://www.cdc.gov/niosh/bsc/</a> or by telephone at
(202) 245-0649 no later than April 14, 2023.
You may submit comments, identified by Docket No. CDC-2023-0015;
NIOSH-278 by either of the methods listed below. CDC does not accept
comments by email.
<bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Follow the instructions for submitting comments.
<bullet> Mail: Ms. Sherri Diana, NIOSH Docket Office, National
Institute for Occupational Safety and Health, 1090 Tusculum Avenue,
Mailstop C-34, Cincinnati, Ohio 45226. Attn: Docket No. CDC-2023-0015;
NIOSH-278.
Instructions: All submissions received must include the Agency name
and docket number. Docket number CDC-2023-0015; NIOSH-278 will close
April 14, 2023.
FOR FURTHER INFORMATION CONTACT: Maria Strickland, M.P.H., Designated
Federal Officer, BSC, NIOSH, CDC, Patriots Plaza 1, 395 E Street SW,
Suite 9200, Washington, DC 20201; Telephone: (202) 245-0649; Email:
MStric<a href="/cdn-cgi/l/email-protection#b9d2d5d8d7dd8bf9daddda97ded6cf"><span class="__cf_email__" data-cfemail="355e59545b5107755651561b525a43">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Background: The Secretary of Health and Human Services, the
Assistant Secretary for Health, and by delegation the Director, Centers
for Disease Control and Prevention, are authorized under Sections 301
and 308 of the Public Health Service Act to conduct directly, or by
grants or contracts, research, experiments, and demonstrations relating
to occupational safety and health and to mine health.
Purpose: The Board of Scientific Counselors, National Institute for
Occupational Safety and Health (BSC, NIOSH) provides advice to the
Director, National Institute for Occupational Safety and Health, on
NIOSH research and prevention programs. The Board also provides
guidance on the Institute's research activities related to developing
and evaluating hypotheses, systematically documenting findings, and
disseminating results. In addition, the Board evaluates the degree to
which the activities of NIOSH: (1) conform to those standards of
scientific excellence appropriate for federal scientific institutions
in accomplishing objectives in occupational safety and health; (2)
address currently relevant needs in the fields of occupational safety
and health either alone or in conjunction with other known activities
inside and outside of NIOSH; and (3) produce their intended results in
addressing important research questions in occupational safety and
health, both in terms of applicability of the research findings and
dissemination of the findings.
Matters to be Considered: The agenda for the meeting addresses Per-
and Polyfluoroalkyl Substances and Occupational Safety and Health
Economics. Agenda items are subject to change as priorities dictate.
The agenda is also posted on the NIOSH website at <a href="https://www.cdc.gov/niosh/bsc/">https://www.cdc.gov/niosh/bsc/</a>.
Public Participation
Written Public Comment: Written comments will be accepted per the
instructions provided in the addresses section above. Comments received
in advance of the meeting are part of the public record and are subject
to public disclosure. Written comments will be included in the official
record of the meeting. Do not include any information in your comment
or supporting materials that you consider confidential or inappropriate
for public disclosure. If you include your name, contact information,
or other information that identifies you in the body of your comments,
that information will be on public display. CDC will review all
submissions and may choose to redact, or withhold, submissions
containing private or proprietary information such as Social Security
numbers, medical information, inappropriate language, or duplicate/
near-duplicate examples of a mass-mail campaign. CDC will carefully
consider all comments submitted into the docket.
Written comments received by April 14, 2023, will be provided to
the Board prior to the meeting.
Oral Public Comment: The public is welcome to participate during
the public comment period, from 1:30 p.m. to 1:45 p.m., EDT, April 21,
2023. Each commenter will be provided up to five minutes for comment. A
limited number of time slots are available and will be assigned on a
first-come, first-served basis. Members of the public who wish to
address the BSC, NIOSH are requested to contact the Designated Federal
Officer for scheduling purposes (see FOR FUTHER INFORMATION CONTACT
above).
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and
[[Page 14372]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-04701 Filed 3-7-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 8, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.